Home/Filings/4/0000899243-22-000459
4//SEC Filing

Bernard Thierry 4

Accession 0000899243-22-000459

CIK 0001492674other

Filed

Jan 3, 7:00 PM ET

Accepted

Jan 4, 3:59 PM ET

Size

9.2 KB

Accession

0000899243-22-000459

Insider Transaction Report

Form 4
Period: 2022-01-01
Transactions
  • Award

    Restricted Stock Units

    2022-01-01+77,51977,519 total
    Common Stock (77,519 underlying)
  • Exercise/Conversion

    Common Stock

    2022-01-01+32,25854,985 total
  • Exercise/Conversion

    Restricted Stock Units

    2022-01-01+32,2580 total
    Common Stock (32,258 underlying)
Footnotes (3)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
  • [F2]On January 1, 2021 the reporting person was granted 32,258 restricted stock units that vested on January 1, 2022.
  • [F3]The restricted stock units were granted in accordance with the Issuer's Non-Employee Director Compensation Plan and vest on January 1, 2023.

Issuer

T2 Biosystems, Inc.

CIK 0001492674

Entity typeother

Related Parties

1
  • filerCIK 0001815490

Filing Metadata

Form type
4
Filed
Jan 3, 7:00 PM ET
Accepted
Jan 4, 3:59 PM ET
Size
9.2 KB